Bone Scan, Healthcare and Pharmaceutical - Diagnostic Imaging Brief

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Bone Scan

Healthcare

Pharmaceutical

FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent

Imaging Technology

JULY 24, 2024

mtaschetta-millane Wed, 07/24/2024 - 11:17 July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) has replaced conventional imaging methods (bone scan, CT scan) as the standard of care after initial diagnosis and biochemical recurrence[5]. The PDUFA[2] goal date is March 24, 2025.

Imaging

Imaging Bone Scan Pharmaceutical Healthcare

AuntMinnie 2007: Gadolinium: A 'necessary factor' in the development of NSF?

AuntMinnie

AUGUST 5, 2024

But grappling with NSF after the fact may be the least troubling issue as healthcare experts scramble to figure out why some patients develop NSF -- and what they can do to prevent NSF from occurring in the first place. Short of a kidney transplant, NSF is difficult to manage. Giles, U.K. Omniscan binds least strongly."

Disease

Disease MRI Radiologist X-ray

FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent

AuntMinnie 2007: Gadolinium: A 'necessary factor' in the development of NSF?

Stay Connected